Pro zobrazení tohoto obsahu je třeba být přihlášen.
Categories for Uncategorized
Circulating tumor DNA analysis using targeted sequencing of 508 clinically actionable genes in patients with high grade serous ovarian cancer
29 septembra, 2020 8:30 pmMeeting: 2017 ASCO Annual Meeting Track: Gynecologic Cancer Abstract number: 5582 Citation: J Clin Oncol 35, 2017...
A randomized phase III trial of cisplatin and tumor volume directed irradiation followed by carboplatin and paclitaxel vs. carboplatin and paclitaxel for optimally debulked, advanced endometrial carcinoma
29 septembra, 2020 8:30 pmMeeting: 2017 ASCO Annual Meeting Track: Gynecologic Cancer Abstract number: 5505 Citation: J Clin Oncol 35, 2017...
Final results of the international randomized PORTEC-3 trial of adjuvant chemotherapy and radiation therapy (RT) versus RT alone for women with high-risk endometrial cancer
29 septembra, 2020 8:30 pmMeeting: 2017 ASCO Annual Meeting Track: Gynecologic Cancer Abstract number: 5502 Citation: J Clin Oncol 35, 2017...
Treatment and outcomes of small cell neuroendocrine carcinoma of the cervix (SCCC)
29 septembra, 2020 8:30 pmMeeting: 2017 ASCO Annual Meeting Track: Gynecologic Cancer Abstract number: 5531 Citation: J Clin Oncol 35, 2017...
Pembrolizumab for previously treated advanced cervical squamous cell cancer: Preliminary results from the phase 2 KEYNOTE-158 study
29 septembra, 2020 8:30 pmMeeting: 2017 ASCO Annual Meeting Track: Gynecologic Cancer Abstract number: 5514 Citation: J Clin Oncol 35, 2017...
An open-label, multicohort, phase I/II study of nivolumab in patients with virus-associated tumors (CheckMate 358): Efficacy and safety in recurrent or metastatic (R/M) cervical, vaginal, and vulvar cancers
29 septembra, 2020 8:30 pmMeeting: 2017 ASCO Annual Meeting Track: Gynecologic Cancer Abstract number: 5504 Citation: J Clin Oncol 35, 2017...
LION: Lymphadenectomy in ovarian neoplasms – A prospective randomized AGO study group led gynecologic cancer intergroup trial
29 septembra, 2020 8:30 pmMeeting: 2017 ASCO Annual Meeting Track: Oral Abstract Session Abstract number: 5500 Citation: J Clin Oncol 35,...
Strategic Combinations in Ovarian Cancer
29 septembra, 2020 8:30 pmJune 3, 2017 The introduction of PARP inhibitors revolutionized the treatment of ovarian cancer, providing much-needed therapeutic options. However,...
Gynekologické malignity – stručný výber z prác prezentovaných na ASCO Annual Meeting 2017
29 septembra, 2020 8:30 pmÚvod Od 2. do 6. júna 2017 sa konal v Chicagu výročný kongres American Society of Clinical Oncology (ASCO), na ktorom sa stretlo viac...
9 weeks vs 1 year adjuvant trastuzumab in combination with chemotherapy: Results of the phase III multicentric Italian study Short-HER
29 septembra, 2020 8:30 pmMeeting: 2017 ASCO Annual Meeting Track: Breast Cancer – Local/Regional/Adjuvant Abstract number: 501 Citation: J Clin Oncol...